Study record

MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway

Zhang W, Li S, Zhang Y et al. · Int Immunopharmacol · 2025

AnimalSeveralEvidence tier CAlso: Cell study (in vitro)Also: Human observational

What this study reported

Found lower serum MOTS-c in adults with asthma than in healthy volunteers. Reported that administered MOTS-c was associated with less lung tissue damage, inflammation, oxidative stress and mitochondrial damage, and with altered airway barrier protein expression, in house dust mite-stimulated mice and in BEAS-2B cells, and that these differences depended on Nrf2 in knockout mice.

Limitations

Human component is a small, undescribed serum comparison with no reported n; animal work uses one mouse strain and one allergen model, and the cell work a single bronchial epithelial line at a supraphysiological exposure.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Speciesmouse, human
System studiedC57BL/6 and Nrf2-knockout mice given house dust mite; BEAS-2B bronchial epithelial cells; serum from adults with asthma and volunteers
PopulationAdults with asthma and healthy volunteers providing serum for MOTS-c measurement
DesignControlled animal and cell experiments with a serum biomarker comparison
Sample size as reportednot reported
Control groupHealthy volunteers; untreated house dust mite-stimulated mice and cells; Nrf2-knockout mice
Route (data field only)Not reported
Endpoints measuredserum MOTS-c; lung histology and injury; airway epithelial barrier proteins; mitochondrial function markers; oxidative stress and inflammation; epithelial apoptosis
Pathways measuredNRF2 / antioxidant response · Apoptosis · Oxidative stress · Inflammation
Research areasLung · Inflammation & immunity · Mitochondrial biology
Evidence tierC — Animal in vivo
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.